FANCM-BTR PPI-IN-1
FANCM-BTR PPI-IN-1 (Comp 32) is a disruptor of the FANCM/ BTR interaction which hampers the FANCM localization to telomeres. FANCM-BTR PPI-IN-1 can be used for cancer research[1].
Product Specifications
CAS Number
3033990-61-0
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fancm-btr-ppi-in-1.html
Purity
98.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(NCC2=CN=CN2)C=C1)(N(C3CCCC3)CC4=CC=C5C(CCCN5CC)=C4)=O
Molecular Formula
C27H35N5O2S
Molecular Weight
493.66
References & Citations
[1]Sandro C, et al. Tetrahydroquinoline compounds as antitumor agents. WO2024068467A1. 2024-04-04
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400281-500 1x 500 µL
Insulin (E2-E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details